MARKET

GLABF

GLABF

GEMINA LABORATORIES LTD
OTCMQB
0.645
+0.050
+8.40%
Closed 13:58 05/14 EDT
OPEN
0.645
PREV CLOSE
0.595
HIGH
0.645
LOW
0.645
VOLUME
1.00K
TURNOVER
645
52 WEEK HIGH
0.907
52 WEEK LOW
0.239
MARKET CAP
48.10M
P/E (TTM)
-19.4864
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at GLABF last week (0505-0509)?
Weekly Report · 2d ago
Weekly Report: what happened at GLABF last week (0428-0502)?
Weekly Report · 05/05 12:26
Weekly Report: what happened at GLABF last week (0421-0425)?
Weekly Report · 04/28 12:40
Weekly Report: what happened at GLABF last week (0414-0418)?
Weekly Report · 04/21 12:40
Weekly Report: what happened at GLABF last week (0407-0411)?
Weekly Report · 04/14 12:23
Weekly Report: what happened at GLABF last week (0331-0404)?
Weekly Report · 04/07 12:23
Weekly Report: what happened at GLABF last week (0324-0328)?
Weekly Report · 03/31 12:40
Weekly Report: what happened at GLABF last week (0317-0321)?
Weekly Report · 03/24 12:23
More
About GLABF
Gemina Laboratories Ltd. is a Canada-based biotechnology company. The Company is a biosensor and binding technologies company with a transformative, patented, proprietary chemistry that powers testing platforms for a range of pathogens that affect human health and wellness. The Company operates in the in vitro diagnostics (IVD) and human wellness monitoring market under the name Gemina Labs. It operates within a single segment, being the research, development and commercialization of in-vitro diagnostics. Its technologies include dual affinity binding mechanism, gold binding protein, cellulose binding protein and more surface binding proteins. Its products include LEGIO X, which is a COVID-19 rapid antigen test, and LEGIO XI, which is a multiplex device that can detect and distinguish between influenza types A and B with no cross reactivity. LEGIO products in development include respiratory syncytial virus and tuberculosis.

Webull offers Gemina Laboratories Ltd stock information, including OTCMQB: GLABF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GLABF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GLABF stock methods without spending real money on the virtual paper trading platform.